|
|
|
|
|
|
Sponsored by: |
University of Arizona |
Information provided by: | University of Arizona |
ClinicalTrials.gov Identifier: | NCT00517647 |
The purpose of this study is to determine if atomoxetine (a common brand name is Strattera), a medicine that is used for treating older children with Attention Deficit and Hyperactivity Disorder (ADHD), is also safe and helpful for ADHD problems in young children. While atomoxetine is not approved by the FDA for use in children younger than 6 years, the FDA has given permission to study this drug in this age group.
Condition | Intervention | Phase |
Attention Deficit Hyperactivity Disorder |
Drug: Atomoxetine |
Phase IV |
MedlinePlus related topics: | Attention Deficit Hyperactivity Disorder |
ChemIDplus related topics: | Atomoxetine Atomoxetine hydrochloride |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Atomoxetine Pilot Study in Preschool Children With ADHD |
Estimated Enrollment: | 40 |
Study Start Date: | April 2004 |
Show Detailed Description |
Ages Eligible for Study: | 3 Years to 5 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jaswinder K Ghuman, M.D. | 520-626-3603 | jkghuman@email.arizona.edu |
United States, Arizona | |||||
University of Arizona Department of Psychiatry | Recruiting | ||||
Tucson, Arizona, United States, 85724 | |||||
Contact: Jaswinder K Ghuman, M.D. 520-626-3603 jkghuman@email.arizona.edu | |||||
Principal Investigator: Jaswinder K Ghuman, M.D. |
University of Arizona |
Principal Investigator: | Jaswinder K Ghuman, M.D. | University of Arizona |
Study ID Numbers: | HSC04-22 |
First Received: | August 15, 2007 |
Last Updated: | August 15, 2007 |
ClinicalTrials.gov Identifier: | NCT00517647 |
Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|